Video: Every Case Tells a Story| Webinar: ACR/CHEST ILD Guidelines in Practice

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

The Case of a 13-Year-Old Girl with Life-Threatening Lupus Onset

Charles Radis, DO  |  Issue: October 2018  |  October 18, 2018

That was the last time she was hospitalized. Over time, she stuck with the medications, even the prednisone, which she hated more than anything. Then one day, six years after the disease first settled in, and with significant trepidation, I discontinued the last 1 mg of prednisone.

Nothing happened.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Not that she was cured. Lupus isn’t cured, it goes into remission. And it wasn’t as if Amanda was off all medications. She kept a pillbox to manage the daily assortment of pills required for high blood pressure, gastritis, depression and anxiety. And of course, I never stopped the hydroxychloroquine or low-dose mycophenolate. Like a good insurance policy, they quietly protected her from lupus rashes and kidney inflammation, and she knew it.

Several years later, Amanda went on to college and returned that fall break to inform me, “Depression is about the past. Anxiety is about the future. If you’re at peace, you’re living in the now,” and then she laughed until tears ran down her cheeks. “No, really, that’s what my psychology professor said last week.” She held up two fingers in a V. “Peace,” and collapsed again in a fit of laughter. She slumped deeper into her chair, twirling a pen. I waited.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“Lupus sucks,” she said. “I know that it sucked when I was 13, and it sucks now, and it’ll suck when—and if—I make it to 30.” She straightened up, half smiling. “But you know, I’m okay with that. Deal me in. You know what I mean? Deal me in.”

And I think I did.


Charles Radis, DO, is clinical professor of medicine at the University of New England, College of Osteopathic Medicine and employed part time at Maine Coast Memorial Hospital in Ellsworth, Maine.

References

  1. Ippolito A, Wallace DJ, Gladman D, et al. Autoantibodies in systemic lupus erythematosus: Comparison of historical and current assessment of seropositivity. Lupus. 2011 Mar;20(3):250–235.
  2. Danchenko N, Satia JA, Anthony MS. Epidemiology of systemic lupus erythematosus: A comparison of worldwide disease burden. Lupus. 2006;15(5):308–318.
  3. Durcan L, Petri M. Why targeted therapies are necessary for systemic lupus erythematosus. Lupus. 2016 Sep;25(10):1070–1079.

Page: 1 2 3 4 5 6 7 8 9 10 11 | Single Page
Share: 

Filed under:ConditionsSystemic Lupus Erythematosus Tagged with:cyclophosphamidekidney failurePericarditisSteroids

Related Articles

    The Rheumatologist as Detective

    February 1, 2015

    A case of difficult-to-diagnose Whipple’s disease

    Age-Related Blood Pressue Patterns in Lupus

    June 15, 2020

    Rheumatologists should not be falsely reassured by a normal mean blood pressure in lupus patients, according to a study from Johns Hopkins University that found age-related blood pressure patterns in systemic lupus erythematosus (SLE) differ from the general population and that increased diastolic blood pressure variability (BPV) is highly associated with cardiovascular events in SLE.1…

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    Diffuse Scleroderma: A 1991 Case Through the Lens of Today

    February 17, 2018

    The year was 1991. It was my first Tuesday as a rheumatology fellow at the University of Pittsburgh’s Presbyterian Hospital. Navigating a maze of buildings and hallways, I delivered myself to the entrance to the scleroderma clinic. Running late and not knowing whether there was a separate entrance for staff, I clicked open the door….

    IgG4-Related Kidney Disease: Diagnostics, Manifestations, & More

    IgG4-Related Kidney Disease: Diagnostics, Manifestations & More

    May 17, 2018

    Immunoglobin G4-related disease (IgG4-RD) is a rare fibro-inflammatory disease of unknown etiology that has been recently recognized. It can cause fibro-inflammatory masses in almost every organ of the body and is associated with dense lymphoplasmacytic infiltration of IgG4-postitive plasma cells, storiform fibrosis and elevated levels of serum IgG4.1 IgG4-RD is a systemic disease that may…

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences